Related references
Note: Only part of the references are listed.Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes
Angelo Antonini et al.
PARKINSONISM & RELATED DISORDERS (2015)
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
Hubert H. Fernandez et al.
MOVEMENT DISORDERS (2015)
Clinical Spectrum of Impulse Control Disorders in Parkinson's Disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2015)
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience
M. Zibetti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
Pedro J. Garcia-Ruiz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
for the LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (vol 13, pg 141, 2014)
C. W. Olen et al.
LANCET NEUROLOGY (2014)
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
Rajesh Pahwa et al.
PARKINSONISM & RELATED DISORDERS (2014)
Percutaneous endoscopic gastrostomy: Indications, technique, complications and management
Ata A. Rahnemai-Azar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow et al.
LANCET NEUROLOGY (2014)
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients
Dag Nyholm et al.
AAPS JOURNAL (2013)
Executive Summary: Heart Disease and Stroke Statistics-2013 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2013)
AFQ056 in Parkinson Patients With Levodopa-Induced Dyskinesia: 13-Week, Randomized, Dose-Finding Study
Fabrizio Stocchi et al.
MOVEMENT DISORDERS (2013)
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
Hubert H. Fernandez et al.
PARKINSONISM & RELATED DISORDERS (2013)
Managing patients with gastrostomy tubes in the community: Can a dedicated enteral feed dietetic service reduce hospital readmissions?
M. Kurien et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2012)
Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease
D. Nyholm et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Perampanel, an AMPA antagonist, found to have no benefit in reducing off time in Parkinson's disease
Andrew Lees et al.
MOVEMENT DISORDERS (2012)
Patterns of disability, care needs, and quality of life of people with Parkinson's disease in a general population sample
D. L. Terriff et al.
PARKINSONISM & RELATED DISORDERS (2012)
Istradefylline for Parkinson's disease patients experiencing motor fluctuations: Results of the KW-6002-US-018 study
Emmanuelle Pourcher et al.
PARKINSONISM & RELATED DISORDERS (2012)
Complications after percutaneous endoscopic gastrostomy in a prospective study
John Blomberg et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Multidisciplinary Practical Guidelines for Gastrointestinal Access for Enteral Nutrition and Decompression From the Society of Interventional Radiology and American Gastroenterological Association (AGA) Institute, With Endorsement by Canadian Interventional Radiological Association (CIRA) and Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
Maxim Itkin et al.
GASTROENTEROLOGY (2011)
Pharmacokinetics of levodopa
Manuela Contin et al.
JOURNAL OF NEUROLOGY (2010)
Regional patterns of brain tissue loss associated with depression in Parkinson disease
V. S. Kostic et al.
NEUROLOGY (2010)
Patient Profile, Indications, Efficacy and Safety of Duodenal Levodopa Infusion in Advanced Parkinson's Disease
David Devos
MOVEMENT DISORDERS (2009)
Pharmacokinetics and pharmacodynamics of levodopa
John G. Nutt
MOVEMENT DISORDERS (2008)
Suicidal and death ideation in Parkinson's disease
Sarra Nazem et al.
MOVEMENT DISORDERS (2008)
A meta-analysis of six prospective studies of falling in Parkinson's disease
Ruth M. Pickering et al.
MOVEMENT DISORDERS (2007)
Emergency hospital admissions in idiopathic Parkinson's disease
H Woodford et al.
MOVEMENT DISORDERS (2005)
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
S Paus et al.
MOVEMENT DISORDERS (2003)
Optimizing levodopa phannacokinetics:: Intestinal infusion versus oral sustained-release tablets
D Nyholm et al.
CLINICAL NEUROPHARMACOLOGY (2003)
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
JE Ahlskog et al.
MOVEMENT DISORDERS (2001)
Share Paper
